OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
April 02, 2019
Easier access to information, targeting smaller patient populations, and increased regulatory focus on patient outcomes are driving patient‑centric drug development.
April 01, 2019
Flexibility and well considered manufacturing approaches could help tablet manufacturers face the increasing pressure resulting from the shifting bio/pharma development landscape.
Market demand and regulatory guidance continues to promote improved medication design.
Modified-release oral dosage forms can offer benefits to both formulation scientists and patients.
March 27, 2019
Valitacell, Solentim, and Microcoat were awarded EUR 3.5 million (US$4 million) to produce an integrated platform to deposit, culture, profile, and select optimal cells for biologic drug manufacturing.
March 26, 2019
Researchers at the Georgia Institute of Technology developed a technique for administering contraceptive hormones through ‘pharmaceutical jewelry’.
March 20, 2019
Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
March 07, 2019
Janssen’s Spravato (esketamine) gains approval with restricted distribution guidelines.
Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid.
March 02, 2019
Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.